Condition: Vitiligo · Non-Segmental Vitiligo (NSV) · Sponsor: Eli Lilly and Company
The purpose of this study is to evaluate how well LY4005130 is tolerated and what side effects may occur in participants with non-segmental vitiligo (NSV) when compared with placebo. The study drug will be administered intravenously (IV) (into a vein in the arm). Blood tests will be performed to investigate how the body processes the study drug and how the study drug affects the body. The study will last approximately 48 weeks, including screening.
This description comes directly from the study's public registry record.
Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or · 1-317-615-4559 · LillyTrials@Lilly.com
Physicians interested in becoming principal investigators please contact · clinical_inquiry_hub@lilly.com
Always discuss trial participation with your own doctor first.
| Medical Dermatology Specialists | Phoenix, Arizona, United States | Recruiting |
| Saguaro Dermatology - Phoenix | Phoenix, Arizona, United States | Not Yet Recruiting |
| Center For Dermatology Clinical Research, Inc. | Fremont, California, United States | Recruiting |
| Northridge Clinical Trials | Northridge, California, United States | Recruiting |
| Cura Clinical Research - Oxnard | Oxnard, California, United States | Recruiting |
| Cura Clinical Research - Santa Clarita - Kelly Johnson Parkway | Santa Clarita, California, United States | Not Yet Recruiting |
| Health Clinical Research, LLC | Miami, Florida, United States | Recruiting |
| K2 Medical Research - Tampa | Tampa, Florida, United States | Recruiting |
| Advanced Medical Research, PC. | Sandy Springs, Georgia, United States | Recruiting |
| Dawes Fretzin Clinical Research Group, LLC | Indianapolis, Indiana, United States | Recruiting |
| Brigham and Women's Hospital | Boston, Massachusetts, United States | Not Yet Recruiting |
| Revival Research Institute, LLC | Troy, Michigan, United States | Recruiting |
+ 23 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07533019